CAS 2050816-56-1

Ravagalimab

CAS : 2050816-56-1

Anti-CD40 monoclonal antibody; for use in the research of Crohn's disease

Ref: 3D-CLA1515

Ravagalimab

CAS : 2050816-56-1

Ravagalimab (ABBV-323) is a CD40 antagonist monoclonal antibody, investigated for Crohn’s disease and Sjögren’s syndrome to evaluate immune modulation.

Degré de pureté : 95% - 96.9% (SDS-PAGE); 99.5% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 145.95 kDa

Ref: TM-T77143